Table 4.
Preemptive (n = 30) | Controls (n = 29) | P | |
---|---|---|---|
Rates (%) of PUQE ≥ 11 in first 3 weeks of NVP | 4 (15.4%) (n = 26) | 9 (39.13%) (n = 23) | P < 0.04 |
AUC of PUQE × Time in 1st trimester (SD) | 6.38 (1.58) (n = 25) | 6.11 (2.24) (n = 22) | NS |
NVP resolved before labor | 18/23 (78.2%) | 11/22 (50%) | <0.002 |
Gest. age when NVP resolved (median wk) | 26 | 33 | 0.18 |
Distribution of HG in previous versus this pregnancy* | |||
HG in previous pregnancy | 19 | 11 | 0.047* |
HG in present pregnancy | 6 | 6 | |
Mean daily dose of Diclectin {mg/kg (SD)} | 0.65 (0.23) | 0.56 (0.24) | 0.2 |
Mean gestational age (in weeks) when NVP symptoms began (SD) |
5.30 (1.02) | 5.45 (1.88) | |
Mean start of preemptive therapy (SD) | 3.8 (0.98) |
AUC = Area under the curve.